Dan Wootton - Concepedia

Author

Dan Wootton

Also Known As

A A R Thompson, Adam Wolverson, Ajay M Shah, D G Wootton, D Wootton, D. G. Wootton, D. Wootton, D.G. Wootton, DG Wootton, Dan G Wootton

139

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

University of Liverpool University of Oxford Aintree University Hospitals NHS Foundation Trust Imperial College London University of Sheffield

About

Dan Wootton is an author at University of Liverpool specializing in medicine, covid-19, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	895
2	Public Health	3	3	380
3	Emergency Medicine	2	2	54
4	Business	1	1	119
5	Allergy	1	1	119

Dan Wootton

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study Andrea Dennis, Małgorzata Wamil, Johann Alberts, BMJ Open	2021	571
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Rachael A Evans, Olivia C. Leavy, Matthew Richardson, The Lancet Respiratory Medicine	2022	407
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine Rebecca Payne, Stephanie Longet, James Austin, Cell	2021	345
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study Clark D Russell, Cameron J Fairfield, Thomas M Drake, The Lancet Microbe Antimicrobial UseInfectious Disease EpidemiologyCovid-19 PandemicHealthcare-associated InfectionProspective Cohort Study	2021	328
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study Adrienn Angyal, Stéphanie Longet, Shona C. Moore, The Lancet Microbe VaccinologyVaccinationImmunologyVaccine TrialCd4 T Cell Responses	2021	174
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study Thomas M Drake, Aya Riad, Cameron J Fairfield, The Lancet	2021	161
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study Iain Stewart, Joseph Jacob, Peter M. George, American Journal of Respiratory and Critical Care Medicine	2022	139
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease Eleanor Barnes, Carl S. Goodyear, Michelle Willicombe, Nature Medicine	2023	124
Household Air Pollution Causes Dose-Dependent Inflammation and Altered Phagocytosis in Human Macrophages Jamie Rylance, Duncan Fullerton, James Scriven, American Journal of Respiratory Cell and Molecular Biology AsthmaInflammatory Lung DiseaseImmunotoxicologyLung InflammationUrban Air Quality	2014	119
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination Felicity Liew, Shubha Talwar, Andy Cross, EBioMedicine VaccinationLong CovidCovid-19 PandemicImmunologyVirology	2022	111

Page 1